Search for a command to run...
Roche Holding AG
Drug Manufacturers - General
| Date | Politician | Asset | Action | Amount | Trade Price | 30D Price | 1M Return | Alpha | 1M Prediction |
|---|---|---|---|---|---|---|---|---|---|
Sep 11, 2026 | Rohit KhannaD | Stock | Sell |
| $15,001 - $50,000 |
| $52.75 |
| $54.09 |
| +2.5% |
| +0.4% |
Jul 11, 2025 | Ritchie John TorresD | Stock | Sell | $1,001 - $15,000 | $39.25 | $37.06 | -5.6% | -7.8% |
Apr 21, 2025 | Bruce WestermanR | Stock | Sell | $1,001 - $15,000 | $37.61 | $38.18 | +1.5% | -11.9% |
Apr 9, 2025 | Josh GottheimerD | Stock | Sell | $1,001 - $15,000 | $35.96 | $37.19 | +3.4% | +0.6% |
Mar 3, 2025 | Bruce WestermanR | Stock | Buy | $1,001 - $15,000 | $40.48 | $39.37 | -2.8% | +0.3% |
CHMP recommends EU approval of Roche’s Ocrevus for children and adolescents with relapsing multiple sclerosis
Ultragenyx prices Sanfilippo gene therapy at $4M; Bristol Myers shelves Orum drug
Roche agrees to $1bn deal with Dualitas for bispecific antibody research
Roche Receives EMA CHMP Recommendation Of Approval Ocrevus For Pediatric Patients With Relapsing Forms Of Multiple Sclerosis
Genentech and Roche Announce Grand Opening of Boston R&D Innovation Center